Table 3.
Factors | N (n death) | HR | Univariate |
Multivariate |
|||
---|---|---|---|---|---|---|---|
95% CI | p-Value | HR | 95% CI | p-Value | |||
Age | 29 | 0.98 | 0.94–1.03 | 0.508 | |||
Fuhrman tumor grade | |||||||
Grade 2 | 14 (10) | 1 | |||||
Grade >2 | 13 (3) | 0.85 | 0.17–4.26 | 0.844 | |||
Performance status | |||||||
0 | 18 (7) | 1 | |||||
1 | 13 (6) | 2.06 | 0.57–7.42 | 0.268 | |||
Heng classification | |||||||
Good | 11 (3) | 1 | |||||
Intermediate | 14 (7) | 2.01 | 0.52–7.79 | 0.314 | |||
Neutrophyle-to-lymphocyte | |||||||
NLR <3 | 20 (7) | 1 | |||||
NLR ≥3 | 4 (3) | 4.95 | 1.15–21.28 | 0.032 | 17.77 | 1.58–200.4 | 0.020 |
Urine biomarker score | 29 | 10.13 | 1.80–57.04 | 0.009 | 16.43 | 2.07–130.5 | 0.008 |
Plasma biomarker score | 30 | 2.23 | 0.79–6.25 | 0.127 |